about
Tolerance, DCs and tryptophan: much ado about IDOOn watching the watchers: IDO and type I/II IFNLack of correlation between DNA-methylating activity and appearance of the immunogenic phenotype in clones of a murine lymphoma treated with mutagensIL-22 and IDO1 affect immunity and tolerance to murine and human vaginal candidiasisIndoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cellsAryl hydrocarbon receptor control of a disease tolerance defence pathwayNEDD4 controls the expression of GUCD1, a protein upregulated in proliferating liver cells.Forced IDO1 expression in dendritic cells restores immunoregulatory signalling in autoimmune diabetesThe cross-talk between opportunistic fungi and the mammalian host via microbiota's metabolism.Therapy of experimental type 1 diabetes by isolated Sertoli cell xenografts alone.Fungi, dendritic cells and receptors: a host perspective of fungal virulence.CTLA-4, T helper lymphocytes and dendritic cells: an internal perspective of T-cell homeostasis.Adaptation of Candida albicans to the host environment: the role of morphogenesis in virulence and survival in mammalian hosts.Microbiota control of a tryptophan-AhR pathway in disease tolerance to fungi.Accumulation of an endogenous tryptophan-derived metabolite in colorectal and breast cancers.Stem cells from human amniotic fluid exert immunoregulatory function via secreted indoleamine 2,3-dioxygenase1.Toll-like receptor 9-mediated induction of the immunosuppressive pathway of tryptophan catabolism.Impaired neutrophil response and CD4+ T helper cell 1 development in interleukin 6-deficient mice infected with Candida albicansA defect in tryptophan catabolism impairs tolerance in nonobese diabetic miceProtective tolerance to fungi: the role of IL-10 and tryptophan catabolism.Receptors and pathways in innate antifungal immunity: the implication for tolerance and immunity to fungi.Tryptophan catabolism in IDO+ plasmacytoid dendritic cells.Thymosin alpha1: an endogenous regulator of inflammation, immunity, and tolerance.Generation of T cell regulatory activity by plasmacytoid dendritic cells and tryptophan catabolism.Controlling pathogenic inflammation to fungi.Indoleamine 2,3-dioxygenase (IDO) in inflammation and allergy to Aspergillus.Immune regulation and tolerance to fungi in the lungs and skin.Indoleamine 2,3-dioxygenase in infection: the paradox of an evasive strategy that benefits the host.CpG Type A Induction of an Early Protective Environment in Experimental Multiple Sclerosis.Toward the identification of a tolerogenic signature in IDO-competent dendritic cells.Indoleamine 2,3-dioxygenase 1 (IDO1) is up-regulated in thyroid carcinoma and drives the development of an immunosuppressant tumor microenvironment.Th17/Treg imbalance in murine cystic fibrosis is linked to indoleamine 2,3-dioxygenase deficiency but corrected by kynurenines.Clotting factor concentrate switching and inhibitor development in hemophilia A.Chemical xenogenization of experimental tumors.A TH1-TH2-like switch in candidiasis: new perspectives for therapy.Cytokines and tumours: problems and perspectives.T helper cell dichotomy to Candida albicans: implications for pathology, therapy, and vaccine design.CD103(+) Dendritic Cells Control Th17 Cell Function in the Lung.IL12 in Candida albicans infections.Neutrophils and the adaptive immune response to Candida albicans.
P50
Q28203295-CDF92979-60AB-4F49-A582-93D037B3E307Q28295567-B4BD9E84-3D78-4B92-8B2B-0924E22309EFQ28339796-0CA0B969-6096-4AF7-A549-6154C9BF3C7AQ28534626-72D39467-E563-4D25-B878-871B1DD930B5Q28588016-B39C5582-14B7-45C0-B9B3-001DFC659ECEQ33901562-D1ED19CD-EE4A-4DFA-81CB-E7BEDF0258D0Q33953101-64B42D97-9277-4BE7-A18D-4CEB374A9D6DQ34323684-CFF7D688-5787-4C8D-A0F7-CE714068C47DQ34448291-F0790507-8AA5-4268-B640-AD4859FFF66EQ34612686-DF011FB6-CE73-4F07-AD09-4CF2778321F2Q34990704-5ED571FE-24B7-4D03-B668-C07563BF6DF2Q35119630-2B7CCDD1-1D95-45D0-8D57-DD0CF3A3E809Q35206887-F77A4BFA-ACCA-4842-BB5A-A28507C3A845Q35277854-63943304-E8D1-485D-AA31-03997216E41EQ35604318-8A121726-8181-4EB9-8172-7F99AE32CE03Q35879522-6757A9A3-3B98-40D8-AE84-9202118E59B2Q36343744-C50B99F3-E484-4DE6-8107-78A077C35FC3Q36366415-76107327-BD80-4DEF-8E0B-AFD3B7E43B40Q36376640-D8B64917-310C-44A8-AB24-AB803DF8CADEQ36413916-445CF316-6810-4D28-841A-B56A9684939CQ36693529-DB8701BE-75D8-402E-B5ED-C8CB528D6991Q36789443-0BA9708E-77DE-491B-80D7-050FDB94CE8CQ36818200-D71E4E94-D55E-48A3-9939-E0310FF0EC33Q36946270-B966870B-D7CB-4234-8F2C-E43ADF6EB2D1Q37014666-DBEF0118-DC48-4E2C-905E-AEF9E90CC798Q37209953-6CDF9055-C445-4642-9561-49C8A0A288E7Q37273146-ADAEEE3F-B9C7-4885-BBFE-BAA05BA63657Q37325190-2729E529-4FBE-449B-B893-A60B8655DFC1Q37710236-C170D305-71D7-485F-AF0A-483E09B0E57DQ38317862-FF1C7156-58A1-490A-BB96-E8171F977062Q39024988-03A6359B-D317-4794-ABD0-7383C56B8EDEQ39488014-DBE6B0F6-548B-43E7-B254-1924A8CED346Q39603925-0E10573F-AD11-4750-ABB2-1F206839F88CQ39658154-8E694D26-9CA6-4E4A-9AA2-ED3185866287Q40466988-57E58AEA-A816-4669-BC7A-CD1076F05373Q40687966-62DA2369-4251-4460-8099-EB475DC86A87Q40928708-76CB411B-7159-41BD-94B0-034AB3FCDC4CQ41002824-F116DBB6-B746-43CA-9B44-8F624629DC6FQ41137299-4CCA8CFD-75D6-46A4-8735-8976FF4F0CF4Q41452254-D2149335-68FF-4AC7-9689-6967F919DBB8
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Paolo Puccetti
@ast
Paolo Puccetti
@en
Paolo Puccetti
@es
Paolo Puccetti
@sl
type
label
Paolo Puccetti
@ast
Paolo Puccetti
@en
Paolo Puccetti
@es
Paolo Puccetti
@sl
prefLabel
Paolo Puccetti
@ast
Paolo Puccetti
@en
Paolo Puccetti
@es
Paolo Puccetti
@sl
P106
P1153
7005908579
P1960
950IJKUAAAAJ
P21
P214
109150033019611180003
P2798
P31
P3762
P496
0000-0001-6674-2128
P735
P7859
viaf-109150033019611180003